Amplitude Surgical Growth Spurred by Foot and Ankle Segment Company Revenue The company's knee and hip replacement sales remain impacted by surgical restrictions, but its foot and ankle line continued its ascent. Feb 21, 2022
Zimmer Biomet Lowers Expectations for 2022 Company Revenue The company grew in the low double digits for 2021 compared to 2020. but expects 2022 to be flat at best, given the market environment. Feb 08, 2022
ConMed Foresees Hospital Staffing Challenges in 2022 Company Revenue The company expects to grow in the mid-single-digits to low double-digits in 2022 but cautioned the year is off to a challenging start. Jan 27, 2022
Orthopedic Companies Spot Opportunity in Ambulatory Settings Market Drivers Forward-thinking orthopedic and spine companies seek to predict and capitalize on the movement of procedures to ambulatory facilities. Jan 18, 2022
VUZE Medical Gains FDA 510(k) for Spinal Surgery Software Robotics/Tech Real-time image processing enables software-only guidance and verification in minimally invasive spine surgery. Jan 18, 2022
Orthopedic Sales Unlikely to See Upside in 4Q Earnings Results Market Analysis The orthopedic market finds itself in familiar territory in early 2022, with record COVID cases impacting elective surgery volumes. Jan 10, 2022
What Orthopedic Companies Need to Know about Hospital Supply Chains Executive Insights The dust is starting to settle about what may be long-term in the orthopedic manufacturer-to-hospital supply chain and what may have been an anomaly. Dec 13, 2021
Stryker’s Return to Orthopedics’ Top Spot Years in the Making Market Analysis Stryker and DePuy Synthes have grappled for the top spot in orthopedic sales for decades. We project that Stryker will reclaim the lead in 2021. Dec 13, 2021
Medtronic Spine Growth Stymied by COVID Headwinds Company Revenue The company grew in the low single digits as enabling technology sales and strength in emerging markets helped offset COVID declines. Nov 29, 2021
Vericel Expects Record MACI Sales to End 2021 Company Revenue The company's MACI product declined in the low single digits for 3Q21 but Vericel expects a record-setting fourth quarter. Nov 17, 2021